Dow Inc (DOW)
Official siteBASIC MATERIALS • CHEMICALS • NYSE
Market Cap: $23.92B
Last updated: Nov 17, 2026 at 11:04 AM ET
Dow Inc (DOW) P/E Ratio & Valuation History
DOW trades at 19.1x trailing earnings and 0.5x sales. Its P/E of 19.1x is below its 5-year median of 20.7x. Its forward P/E is 17.6x. The median P/E across 10 similar companies is 14.1x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 8.5% higher over the next year. Its free cash flow yield is 9.1%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 19.1x |
| Forward P/E | 17.6x |
| Price to sales | 0.5x |
| Price to book | 1.4x |
| EV/EBITDA | 11.1x |
| Price to FCF | 11.0x |
| EV/FCF | 17.8x |
| PEG | 0.5 |
| FCF yield | 9.1% |
Historical Medians
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 19.1x | 20.7x | N/A |
| P/S | 0.5x | 0.7x | N/A |
| P/B | 1.4x | 1.9x | N/A |
Valuation History
Over the 6 of the 7 year ends shown that have a P/E, its P/E ranged from 6.3x in 2021 to 33.8x in 2020.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $23.38 | N/A | 0.4x | 1.0x |
| 2024 | $40.13 | 24.5x | 0.7x | 1.6x |
| 2023 | $54.84 | 24.5x | 0.9x | 2.1x |
| 2022 | $50.39 | 8.1x | 0.6x | 1.7x |
| 2021 | $56.72 | 6.3x | 0.8x | 2.3x |
| 2020 | $55.50 | 33.8x | 1.1x | 3.3x |
| 2019 | $54.73 | 16.8x | 0.9x | 3.0x |
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About DOW
What is DOW's forward P/E ratio?
DOW has a forward P/E ratio of 17.6x.
Is DOW stock overvalued?
GNG's valuation label for DOW is Fairly valued. Its P/E of 19.1x compares with a median of 14.1x across 10 similar companies.
What is DOW's price to sales ratio?
DOW has a price to sales ratio of 0.5x.
What is DOW's average P/E ratio over 5 years?
DOW's median P/E over the last 5 years is 20.7x, from 48 month-end values through Oct 2026.
What is DOW's PEG ratio?
DOW has a PEG ratio of 0.5.
DOW pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors